₹22.07
as on
as on September 8, 2025 at 4:01 pm IST
Day's Low
Day's High
1.31%
Downside
1.90%
Upside
52 Week's Low
52 Week's High
13.91%
Downside
62.57%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹96.72 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.72
P/B Ratio
-4.09
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
59.74
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Bharat Immunological & Biological Corporation Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 96.72 | -7.45% | 0.00 | -18 | 44 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Bharat Immunological & Biological Corporation Ltd Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Bharat Immunological & Biological Corporation Ltd.
Bharat Immunological & Biological Corporation Ltd’s net profit fell -59.74% since last year same period to ₹-4.92Cr in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated -7.19% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 40.75% of holdings in Mar 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 163.4%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 16.2% return, outperforming this stock by 36.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.25% of holdings in Mar 2024 quarter
Price Dip
In the last 3 years, Bharat Immunolog stock has moved down by -26.3%
Organisation | Bharat Immunological & Biological Corporation Ltd |
Industry | Pharmaceuticals |
CEO | Y K Gupta |
E-voting on shares | Click here to vote |
Bharat Immunological & Biological Corporation Ltd share price today stands at ₹22.07 as on at the close of the market. Bharat Immunological & Biological Corporation Ltd share today touched a day high of ₹22.49 and a low of ₹21.78.
Bharat Immunological & Biological Corporation Ltd touched a 52 week high of ₹35.88 and a 52 week low of ₹19. Bharat Immunological & Biological Corporation Ltd share price today i.e. is closed at ₹22.07, which is -38.49% down from its 52 week high and 16.16% up from its 52 week low.
Bharat Immunological & Biological Corporation Ltd market capitalisation is ₹96.72 Cr as on .
To buy Bharat Immunological & Biological Corporation Ltd shares, you need to follow these steps:
Bharat Immunological & Biological Corporation Ltd trading volume is 37.02K as on . This means that 37.02K shares of Bharat Immunological & Biological Corporation Ltd were bought and sold on the stock market during today's trading session.